ANDA 76439, held by Rising. Brimonidine Tartrate.
As of Nov 16, 2026, ANDA 76439 (Brimonidine Tartrate), held by Rising, was first approved by FDA on Mar 14, 2006, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 14, 2006 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Brimonidine Tartrate0.2% · solution/drops;ophthalmic | Brimonidine Tartrate | Rx |
| Oct 10, 2016 | Supplement 1Labeling · Standard review | Approved | None posted |
| Mar 14, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters